CClinicalTrials.gg
CompletedNCT05384327Updated May 9, 2023

Development and Validation of a Theoretical Test for Chest Tube Insertion

An interventional study of Interview and Multiple Choice Question (MCQ) Test in Chest Tubes and Cognitive Skill, sponsored by University Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-09.

Sponsored by University Ghent · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of the proposed study design is to develop and gather validity evidence of a theoretical test about cognitive skills which are important when performing Chest Tube Insertion (CTI). This study consists of two parts:

  • The development of the theoretical test and its items. The test content will be based on a broad literature search, and on semi-structured interviews with content experts.
  • The subsequent collection of validity evidence for this theoretical test and final selection of the test items, by testing groups that differ based on their expertise. The item analysis and observed difference in mean score between the groups will provide the validity evidence.
02

Conditions studied

  • Chest Tubes
  • Cognitive Skill

Keywords

  • Chest Tube
  • Assessment
03

In context

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Content experts will be recruited from the departments of surgery, pulmonology, and emergency medicine of various hospitals in Flanders and the Netherlands. They must have finished their residency training and be actively involved in training of junior physicians. A maximum of six experts will be recruited, and a minimum of one physician from each department will be included.
  • The novice group will attract medical students at Ghent University, within their 5th or 6th year of undergraduate training, while having no experience with CTI.
  • The intermediate group will include residents of the departments of surgery, pulmonology and emergency medicine of Ghent University Hospital, within their 1st - 3rd year of residency training and must have placed less than 20 chest tubes themselves.
  • The experienced group will be recruited from the departments of surgery, pulmonology, and emergency medicine of Ghent University Hospital. They must have finished the residency training in their respective fields and must have performed more than 20 CTI independently. The content experts will not be eligible for participation.

Exclusion criteria

Exclusion Criteria:

  • For the novice and intermediate group: having to much experience in CTI.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
55 participants (actual)

Study arms

  • Other
    Interview

    Content experts who will be interviewed in order to collect their opinion on theoretical knowledge.

    Other: Interview

  • Other
    Novices

    Medical students who will complete the test

    Other: Multiple Choice Question (MCQ) Test

  • Other
    Intermediates

    Junior residents (surgery, pneumology, emergency medicine) who will complete the test.

    Other: Multiple Choice Question (MCQ) Test

  • Other
    Experienced

    Faculty members (surgery, pneumology, emergency medicine) who will complete the test.

    Other: Multiple Choice Question (MCQ) Test

Interventions

  • OtherInterview

    Interviews consist of semi-structured interviews focused on the theoretical knowledge a physician should possess before placing chest tube insertions.

  • OtherMultiple Choice Question (MCQ) Test

    The test contains multiple choice questions based on these interviews. Participants will complete this test. Validity evidence will be collected based on the results of this test.

06

What researchers measure

Primary outcomes

  1. Validity evidence for the theoretical test

    Validity evidence following Messick's framework for a new theoretical test will be collected. The score will reflect the number of questions participants scored correctly; X/Y, where X=the number of questions answered correctly, and Y=the total number of questions. This score can be transformed in a percentage score accordingly. A higher score means the participant answered more questions correctly.

    Time frame: Participants are assessed once: the score of each participant is recorded immediately after completion of the test.

07

Study locations

1 site
  • Ghent University Hospital
    Ghent, Oost-Vlaanderen 9000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05384327
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
May 20, 2022
Start date
May 5, 2022
Primary completion
Apr 18, 2023
Completion
Apr 18, 2023
Last update
May 9, 2023

Study contacts

Wouter Willaert, Prof. Dr.
principal investigator · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion